Kevin Starr

Kevin Starr is a proven operational leader with more than 25 years of experience building and operating leading biotech companies. Mr. Starr co-founded Third Rock Ventures in 2007 and focuses on the formation, development, and business strategy of the firm's portfolio companies as well as actively identifying and evaluating new investments. Before Third Rock Ventures, Mr. Starr was Chief Operating Officer and Chief Financial Officer at Millennium Pharmaceuticals, where he led key roles in raising billions of dollars in capital through strategic alliances and public financing and driving growth through company expansion and mergers and acquisitions.

Earlier in his career, he served in various executive roles at Millennium BioTherapeutics, Biogen, and Digital Equipment Corporation. He is currently a Board Member and Start-Up CEO of Sage Therapeutics. Mr. Starr holds an M.S. in Corporate Finance from Boston College and a B.A. in Mathematics and Business from Colby College.

Kevin Starr is the Board Member, Start-Up CEO at SAGE Therapeutics, based in United States, North America. With a background in Biotechnology, Kevin Starr has a rich history of leadership and innovation. Kevin Starr studied MS Corporate Finance @ Boston College. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.